0001209191-16-096129.txt : 20160205 0001209191-16-096129.hdr.sgml : 20160205 20160205191935 ACCESSION NUMBER: 0001209191-16-096129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160205 FILED AS OF DATE: 20160205 DATE AS OF CHANGE: 20160205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evoke Pharma Inc CENTRAL INDEX KEY: 0001403708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208447886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 LOMAS SANTA FE DRIVE STREET 2: SUITE 270 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-345-1494 MAIL ADDRESS: STREET 1: 505 LOMAS SANTA FE DRIVE STREET 2: SUITE 270 CITY: SOLANA BEACH STATE: CA ZIP: 92075 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: D'Onofrio Matthew J CENTRAL INDEX KEY: 0001578770 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36075 FILM NUMBER: 161393660 MAIL ADDRESS: STREET 1: C/O EVOKE PHARMA, INC. STREET 2: 12555 HIGH BLUFF DR SUITE 385 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-05 0 0001403708 Evoke Pharma Inc EVOK 0001578770 D'Onofrio Matthew J C/O EVOKE PHARMA, INC. 505 LOMAS SANTA FE DRIVE, SUITE 270 SOLANA BEACH CA 92075 0 1 0 0 Exec VP, Chief Bus. Officer Stock Option (Right to Buy) 8.67 2016-02-05 4 D 0 94250 D 2023-12-01 Common Stock 94250 0 D Stock Option (Right to Buy) 6.22 2016-02-05 4 D 0 70000 D 2025-03-05 Common Stock 70000 0 D Stock Option (Right to Buy) 3.04 2016-02-05 4 A 0 70687 0.00 A 2023-12-01 Common Stock 70687 70687 D Stock Option (Right to Buy) 3.04 2016-02-05 4 A 0 52500 0.00 A 2025-03-05 Common Stock 52500 52500 D The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period following the date of grant (12/2/2013), subject to the reporting person's continued service to the Issuer through each such vesting date. On February 5, 2016, the Issuer canceled an option granted on December 2, 2013. In exchange for the canceled option, the reporting person received 70,687 options to purchase common stock. The total number of shares of common stock subject to the option vests in 48 equal monthly installments over the four-year period beginning on January 1, 2015, subject to the reporting person's continued service to the Issuer through each such vesting date. On February 5, 2016, the Issuer canceled an option granted on March 6, 2015. In exchange for the canceled option, the reporting person received 52,500 options to purchase common stock. The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on January 1, 2016, subject to the reporting person's continued service to the Issuer through each such vesting date. /s/ Matthew J. D'Onofrio 2016-02-05